StonvexLoading…
StonvexStonvexStonvexCore line items from OPTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $6.51M | $28.08M | $20.58M | $13.63M |
Operating Income | $-776.05K | $-517.60K | $-836.40K | $382.20K |
Net Income | $-897.86K | $-1.79M | $-1.45M | $-343.92K |
EPS (Diluted) | $-0.02 | $-0.05 | $-0.04 | $0.00 |
Total Assets | $23.50M | $24.31M | $24.58M | $25.30M |
Total Liabilities | $14.78M | $14.77M | $14.77M | $14.28M |
Cash & Equivalents | $617.01K | $358.87K | $577.92K | $287.08K |
Free Cash Flow OCF − CapEx | $175.29K | $28.34K | $32.72K | $-463.53K |
Shares Outstanding | 36.95M | 36.92M | 36.92M | 36.92M |